Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07164742

Parent Study Name: Pulmonary Rehabilitation to Reduce Post-Tuberculosis Morbidity (TB Pure)

Pulmonary Rehabilitation to Reduce Post-Tuberculosis Morbidity (TB PURE) A Randomized Multi-Centre Trial

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
690 (estimated)
Sponsor
Johns Hopkins University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Individual-level, unblinded randomized controlled trial of an 8-week (short arm) or 24-week (extended arm) pulmonary rehabilitation program, relative to standard of care, to prevent post-tuberculosis respiratory morbidity. Randomization will occur in a 1:1:1 ratio at the initiation of treatment.

Detailed description

8 weeks (short arm) or 24 weeks (extended arm) of a pulmonary rehabilitation (PR) program, administered during TB treatment, comprising of exercise training, counselling and education, and airway clearance techniques. Objectives: 1. To compare the effectiveness of two home-based PR programs, administered during TB treatment, for preventing post-TB respiratory morbidity. 2. To describe the intersection between clinic-level service organization, fidelity of intervention delivery, and change in client behavior for the two PR programs. 3. To compare the costs, cost-effectiveness, and budget impact of the two different PR strategies implemented as a routine program.

Conditions

Interventions

TypeNameDescription
BEHAVIORAL8 week (short arm) Intervention - pulmonary rehabilitation8 weeks (short arm) of a pulmonary rehabilitation (PR) program, administered during TB treatment, comprising of exercise training, counselling and education, and airway clearance techniques.
BEHAVIORAL24 week (long arm) Intervention - pulmonary rehabilitation24 weeks (extended arm) of a pulmonary rehabilitation (PR) program, administered during TB treatment, comprising of exercise training, counselling and education, and airway clearance techniques.

Timeline

Start date
2026-03-18
Primary completion
2028-09-15
Completion
2028-09-15
First posted
2025-09-10
Last updated
2026-03-27

Locations

2 sites across 1 country: India

Source: ClinicalTrials.gov record NCT07164742. Inclusion in this directory is not an endorsement.